Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
ProKidney (PROK)
NASDAQ:PROK
PROK Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.34 - $4.44
Previous CloseN/A
Volume58.77K
Average Volume (3M)376.11K
Market Cap
$443.40M
Enterprise Value$1.27B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta2.13
Next Earnings
Apr 01, 2025EPS Estimate
-0.15Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.56
Shares Outstanding127,968,250
10 Day Avg. Volume342,332
30 Day Avg. Volume376,113
Standard Deviation0.23
R-Squared0.09
Alpha-0.03
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-3.80
P/FCF Ratio0.00
Enterprise Value/Market Cap2.85
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-399.20
Enterprise Value/Ebitda-9.58
Forecast
1Y Price Target
$3.00Price Target Upside100.00% Upside
Rating ConsensusHold
Number of Analyst Covering1
---
ProKidney News
PremiumCompany Announcements
ProKidney’s Progress in FDA Approval and Financial Health
PremiumCompany Announcements
ProKidney: Investor Update and Phase 3 Program Progress---
Bulls Say, Bears Say
Bulls Say
Market PotentialRilparencel is a differentiated approach in diabetic CKD with blockbuster potential.
Regulatory ProgressFDA confirmed that PROACT 1 could be sufficient to support a BLA submission and full approval.
Bears Say
Financial ConcernsTopline results for the PROACT 1 study are expected in 3Q27, beyond the company's current cash runway.
---
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
PROK FAQ
What was ProKidney’s price range in the past 12 months?
ProKidney lowest stock price was $1.34 and its highest was $4.44 in the past 12 months.
What is ProKidney’s market cap?
ProKidney’s market cap is $443.40M.
When is ProKidney’s upcoming earnings report date?
ProKidney’s upcoming earnings report date is Apr 01, 2025 which is in 37 days.
How were ProKidney’s earnings last quarter?
ProKidney released its earnings results on Nov 12, 2024. The company reported -$0.14 earnings per share for the quarter, missing the consensus estimate of -$0.128 by -$0.012.
Is ProKidney overvalued?
According to Wall Street analysts ProKidney’s price is currently Undervalued.
Does ProKidney pay dividends?
ProKidney does not currently pay dividends.
What is ProKidney’s EPS estimate?
ProKidney’s EPS estimate is -0.15.
How many shares outstanding does ProKidney have?
ProKidney has 127,968,250 shares outstanding.
What happened to ProKidney’s price movement after its last earnings report?
ProKidney reported an EPS of -$0.14 in its last earnings report, missing expectations of -$0.128. Following the earnings report the stock price went down -4.651%.
Which hedge fund is a major shareholder of ProKidney?
Currently, no hedge funds are holding shares in PROK
---
ProKidney Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$3.00 (100.00% Upside)
$3.00 (100.00% Upside)
Blogger Sentiment
Bullish
PROK Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 17.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.7%
Last 30 Days ▼ 6.5%
Last 30 Days ▼ 6.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-1.31%
12-Months-Change
Fundamentals
Return on Equity
4.66%
Trailing 12-Months
Asset Growth
5.09%
Trailing 12-Months
Company Description
ProKidney
Social Capital Suvretta Holdings Corp III is a blank check company.
---
PROK Stock 12 Month Forecast
Average Price Target
$3.00
▲(100.00% Upside)
Technical Analysis
Fate Therapeutics
―
Rocket Pharmaceuticals
―
Crispr Therapeutics AG
―
Allakos
―
Mirum Pharmaceuticals
―
Best Analysts Covering PROK
1 Year
1 Year Success Rate
1/9 ratings generated profit
1 Year Average Return
-38.59%
reiterated a buy rating 6 months ago
Copying Justin Zelin's trades and holding each position for 1 Year would result in 11.11% of your transactions generating a profit, with an average return of -38.59% per trade.
---